Home » Topics » Regulatory

Regulatory
RSS

Zomig-ZMT now available in U.S. for treatment of migraine

June 8, 2001

Celltech launches Metadate CD for ADHD in U.S.

June 6, 2001

Oral suspension of Trileptal for epilepsy approved by FDA

June 5, 2001

New dose of Teveten now available in Canada

May 31, 2001

Takeda's Ixense approved in Europe for ED

May 30, 2001

Novartis launches Foradil Aerolizer in the U.S.

May 30, 2001

Femara approved in Canada as first-line treatment for advanced breast cancer

May 24, 2001

FDA accepts for review Roche's sNDA for new Xenical indication

May 23, 2001

Effexor gains new FDA labeling approval regarding relapse

May 21, 2001

Statistically significant reductions in BP reported for enalapril/nitrendipine

May 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...